VistaGen Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by VistaGen Therapeutics, Inc. on June 3, 2013, covering events occurring on May 28, 2013. The filing details amendments to existing financing agreements and updates on a pending capital raise.
Key Financial Metrics and Agreements
- Warrant Price Adjustment: The exercise price of approximately 3.27 million Common Stock warrants issued to Platinum Long Term Growth VII, LLC was reduced to $0.50 per share.
- Pending Financing: A $36 million investment commitment from Bergamo Acquisition Corp. for 72 million shares at $0.50 per share remains pending.
- Historical Debt: The warrant adjustment relates to $3.25 million of promissory notes purchased by Platinum in October 2012.
Material Changes and Events
On May 28, 2013, the Company entered into an Amendment and Waiver with Platinum. In exchange for Platinum waiving certain anti-dilution provisions regarding approved dilutive issuances, the Company reduced the warrant exercise price. Additionally, the Company reported a delay in the initial closing of the Bergamo Financing, originally scheduled for May 2013, due to administrative delays in international funds transfers.
Outlook, Risks, and Management Commentary
Management anticipates that the initial funding from Bergamo, originally scheduled for May 2013, will be completed in June 2013. Subsequent monthly closings are expected to proceed according to the amended Securities Purchase Agreement terms ending September 30, 2013. The filing includes standard forward-looking statement disclaimers regarding significant risks and uncertainties affecting these expectations.
Investor Verification Checklist
- Verify the execution of the initial closing of the $36 million Bergamo Financing in June 2013.
- Review the full text of the Amendment and Waiver (Exhibit 10.1) to understand the specific anti-dilution provisions waived by Platinum.
- Monitor the Company's cash position given the delay in the Bergamo funding.
- Confirm the status of the monthly closing schedule for the Bergamo Financing through September 2013.